During the past decade, IFE Human Pharmacology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IFE Human Pharmacology" are "Chronic Constipation" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "IFE Human Pharmacology" in a lesser frequency.

Most popular intervention types in "IFE Human Pharmacology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Betahistine" (1 trials), "PEG 3350 plus electrolytes" (1 trials) and "PEG 3350 without electrolytes" (1 trials). Other intervention names were less common.

The vast majority of trials in "IFE Human Pharmacology" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "IFE Human Pharmacology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in IFE Human Pharmacology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IFE Human Pharmacology, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".